Wockhardt announces exit from generic drugs business in US
Pharma company Wockhardt stated in a regulatory filing on Friday that it will exit from the US generic drugs market.
Pharma company Wockhardt stated in a regulatory filing on Friday that it will exit from the US generic drugs market.
Of this, the mandatory borrowing to be done through issuance of debt securities (25 per cent of incremental borrowing) was Rs 5,467.50 crore.
